Proton pump inhibitors (PPIs) are medicines commonly prescribed to treat acid-related digestive problems, including gastroesophageal reflux disease (or GERD). As of 2011, up to 1 in 5 older adults reported using a PPI. Although ...
Nov 21, 2017
0
1
(HealthDay)—Long-term proton pump inhibitor (PPI) use is associated with increased risk of gastric cancer (GC) even after Helicobacter pylori (HP) eradication therapy, according to a study published online Oct. 31 in Gut.
Nov 2, 2017
0
0
The long term use of proton pump inhibitors (PPIs), a class of drugs commonly used to treat acid reflux, is linked to a more than doubling in the risk of developing stomach cancer, finds research published online in the journal ...
Oct 31, 2017
0
35
Researchers at Texas Tech University Health Sciences Center (TTUHSC) investigated a pump-induced disease and defined the molecular mechanism that triggers it. The study, "On the effect of hyperaldosteronism-inducing mutations ...
Oct 26, 2017
0
0
Compared with insulin injections, insulin pump therapy among young patients with type 1 diabetes was associated with a lower risk of diabetic ketoacidosis and severe hypoglycemia, according to a study published by JAMA.
Oct 10, 2017
0
0
Abbott Laboratories has gained clearance to start selling in the U.S. the first continuous glucose monitor that does not require people with diabetes to routinely prick their fingers.
Oct 4, 2017
0
2
(HealthDay)—Children with CYP2C19*17 alleles without corresponding loss-of-function alleles have longer times with pH
Sep 26, 2017
0
1
Many people suffer regularly from heartburn - a burning feeling in the chest caused by stomach acid travelling up the food pipe (oesophagus) after eating. This causes inflammation and irritation of the lower oesophagus, and ...
Aug 10, 2017
0
0
The use of proton pump inhibitors does not increase the risk of Alzheimer's disease, shows a recent study from the University of Eastern Finland. Proton pump inhibitors are a type of antiulcer drug that is commonly used among ...
Aug 7, 2017
0
1
People who take proton pump inhibitors for stomach acid reflux run a greater risk of chronic kidney disease than those who take H2-receptor antagonists for the same complaint, a new study published in Gastroenterology reports.
Aug 4, 2017
0
0
